Literature DB >> 15777205

Determination of binding constant of DNA-binding drug to target DNA by surface plasmon resonance biosensor technology.

Liang-Ping Lin1, Long-Sun Huang, Chii-Wann Lin, Chi-Kung Lee, Ji-Liang Chen, Su-Ming Hsu, Shiming Lin.   

Abstract

The experimental determination of the binding constant of a drug for its target molecule is of considerable importance. It is a basic experimental parameter in a variety of studies, such as the prediction of drug efficiency, or in the pharmacokinetic drug interaction. DNA-binding drugs have been reported to be able to interfere in a sequence dependent manner with biological functions such as topoisomerase activity, restriction of enzyme cleavage of DNA, protein-DNA interactions and the activity of transcription factors, leading to alteration of gene expression. This effect could have important practical application in the experimental therapy of human pathologies, including neoplastic diseases and viral, or microbial infections. The assessment of the biological activity of DNA-binding drugs by polymerase chain reaction, footprinting, gel retardation and in vitro transcription studies was recently reported. However, most of these techniques are steady-state methodologies and therefore are not suitable for an easy determination of the binding activity of DNA-binding drugs to target DNA and the stability of drugs-DNA complexes. Direct real-time observation and measurement of the interaction between DNA-binding drug and target DNA sequence is a subject of interest for drug discovery and development. The recent development of biosensors, based on surface plasmon resonance (SPR) technology, enables monitoring of a variety of biospecific interactions of DNA-binding drugs with target DNA elements in real-time. The present review is designed to indicate the theoretical background of SPR-based biosensor technology as well as to present the great variety of measurements and modes of interaction kinetics that can be performed with these techniques. In addition, some of the most recent studies in determining the binding constant and stoichiometry of DNA-binding drugs to target DNA with SPR technology are reviewed and the available theoretical aspects necessary for the comprehension of the experiments are provided.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15777205     DOI: 10.2174/1568008053174697

Source DB:  PubMed          Journal:  Curr Drug Targets Immune Endocr Metabol Disord        ISSN: 1568-0088


  8 in total

1.  Kinetic analysis of IgM monoclonal antibodies for determination of dengue sample concentration using SPR technique.

Authors:  Peyman Jahanshahi; Qin Wei; Zhang Jie; Mostafa Ghomeishi; Shamala Devi Sekaran; Faisal Rafiq Mahamd Adikan
Journal:  Bioengineered       Date:  2016-08-17       Impact factor: 3.269

2.  Evaluation of molecular descriptors for antitumor drugs with respect to noncovalent binding to DNA and antiproliferative activity.

Authors:  José Portugal
Journal:  BMC Pharmacol       Date:  2009-09-16

3.  Immobilizing topoisomerase I on a surface plasmon resonance biosensor chip to screen for inhibitors.

Authors:  Hsiang-Ping Tsai; Li-Wei Lin; Zhi-Yang Lai; Jui-Yu Wu; Chiao-En Chen; Jaulang Hwang; Chien-Shu Chen; Chun-Mao Lin
Journal:  J Biomed Sci       Date:  2010-06-17       Impact factor: 8.410

4.  Contrasting enantioselective DNA preference: chiral helical macrocyclic lanthanide complex binding to DNA.

Authors:  Chuanqi Zhao; Jinsong Ren; Janusz Gregoliński; Jerzy Lisowski; Xiaogang Qu
Journal:  Nucleic Acids Res       Date:  2012-06-06       Impact factor: 16.971

5.  A therapeutic chemical chaperone inhibits cholera intoxication and unfolding/translocation of the cholera toxin A1 subunit.

Authors:  Michael Taylor; Tuhina Banerjee; Fernando Navarro-Garcia; Jazmin Huerta; Shane Massey; Mansfield Burlingame; Abhay H Pande; Suren A Tatulian; Ken Teter
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

Review 6.  What Can Electrochemical Methods Offer in Determining DNA-Drug Interactions?

Authors:  Sandra Ramotowska; Aleksandra Ciesielska; Mariusz Makowski
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

7.  DNA-metallodrugs interactions signaled by electrochemical biosensors: an overview.

Authors:  Mauro Ravera; Graziana Bagni; Marco Mascini; Domenico Osella
Journal:  Bioinorg Chem Appl       Date:  2007       Impact factor: 7.778

8.  Molecular Fingerprints of Hemoglobin on a Nanofilm Chip.

Authors:  Yeşeren Saylan; Adil Denizli
Journal:  Sensors (Basel)       Date:  2018-09-09       Impact factor: 3.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.